These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 27657380)
1. The histone deacetylase inhibitor romidepsin synergizes with lenalidomide and enhances tumor cell death in T-cell lymphoma cell lines. Cosenza M; Civallero M; Fiorcari S; Pozzi S; Marcheselli L; Bari A; Ferri P; Sacchi S Cancer Biol Ther; 2016 Oct; 17(10):1094-1106. PubMed ID: 27657380 [TBL] [Abstract][Full Text] [Related]
2. The combination of bortezomib with enzastaurin or lenalidomide enhances cytotoxicity in follicular and mantle cell lymphoma cell lines. Cosenza M; Civallero M; Pozzi S; Marcheselli L; Bari A; Sacchi S Hematol Oncol; 2015 Dec; 33(4):166-75. PubMed ID: 25394177 [TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase inhibitor romidepsin induces efficient tumor cell lysis via selective down-regulation of LMP1 and c-myc expression in EBV-positive diffuse large B-cell lymphoma. Shin DY; Kim A; Kang HJ; Park S; Kim DW; Lee SS Cancer Lett; 2015 Aug; 364(2):89-97. PubMed ID: 25790907 [TBL] [Abstract][Full Text] [Related]
10. MAPK pathway activation leads to Bim loss and histone deacetylase inhibitor resistance: rationale to combine romidepsin with an MEK inhibitor. Chakraborty AR; Robey RW; Luchenko VL; Zhan Z; Piekarz RL; Gillet JP; Kossenkov AV; Wilkerson J; Showe LC; Gottesman MM; Collie NL; Bates SE Blood; 2013 May; 121(20):4115-25. PubMed ID: 23532732 [TBL] [Abstract][Full Text] [Related]
11. Blocking NF-κB sensitizes non-small cell lung cancer cells to histone deacetylase inhibitor induced extrinsic apoptosis through generation of reactive oxygen species. Karthik S; Sankar R; Varunkumar K; Anusha C; Ravikumar V Biomed Pharmacother; 2015 Feb; 69():337-44. PubMed ID: 25661379 [TBL] [Abstract][Full Text] [Related]
12. Dual Inhibition of Histone Deacetylases and the Mechanistic Target of Rapamycin Promotes Apoptosis in Cell Line Models of Uveal Melanoma. Patel RP; Thomas JR; Curt KM; Fitzsimmons CM; Batista PJ; Bates SE; Gottesman MM; Robey RW Invest Ophthalmol Vis Sci; 2021 Sep; 62(12):16. PubMed ID: 34533562 [TBL] [Abstract][Full Text] [Related]
14. PCI-24781 induces caspase and reactive oxygen species-dependent apoptosis through NF-kappaB mechanisms and is synergistic with bortezomib in lymphoma cells. Bhalla S; Balasubramanian S; David K; Sirisawad M; Buggy J; Mauro L; Prachand S; Miller R; Gordon LI; Evens AM Clin Cancer Res; 2009 May; 15(10):3354-65. PubMed ID: 19417023 [TBL] [Abstract][Full Text] [Related]
15. Chidamide-Induced Accumulation of Reactive Oxygen Species Increases Lenalidomide Sensitivity Against Multiple Myeloma Cells. Jiang D; Zhang K; Zhu Y; Zhu Y; Zou L; Hu J; Cui Y; Zhou W; Chen F; He Y Onco Targets Ther; 2021; 14():4061-4075. PubMed ID: 34262292 [TBL] [Abstract][Full Text] [Related]
16. Synergistic interaction of the histone deacetylase inhibitor SAHA with the proteasome inhibitor bortezomib in mantle cell lymphoma. Heider U; von Metzler I; Kaiser M; Rosche M; Sterz J; Rötzer S; Rademacher J; Jakob C; Fleissner C; Kuckelkorn U; Kloetzel PM; Sezer O Eur J Haematol; 2008 Feb; 80(2):133-42. PubMed ID: 18005386 [TBL] [Abstract][Full Text] [Related]
17. Romidepsin (depsipeptide) induced cell cycle arrest, apoptosis and histone hyperacetylation in lung carcinoma cells (A549) are associated with increase in p21 and hypophosphorylated retinoblastoma proteins expression. Vinodhkumar R; Song YS; Devaki T Biomed Pharmacother; 2008 Feb; 62(2):85-93. PubMed ID: 17644301 [TBL] [Abstract][Full Text] [Related]
18. Synergistic interaction of the histone deacetylase inhibitor SAHA with the proteasome inhibitor bortezomib in cutaneous T cell lymphoma. Heider U; Rademacher J; Lamottke B; Mieth M; Moebs M; von Metzler I; Assaf C; Sezer O Eur J Haematol; 2009 Jun; 82(6):440-9. PubMed ID: 19220424 [TBL] [Abstract][Full Text] [Related]
19. Romidepsin (FK228/depsipeptide) controls growth and induces apoptosis in neuroblastoma tumor cells. Panicker J; Li Z; McMahon C; Sizer C; Steadman K; Piekarz R; Bates SE; Thiele CJ Cell Cycle; 2010 May; 9(9):1830-8. PubMed ID: 20404560 [TBL] [Abstract][Full Text] [Related]